9800 Mount Pyramid Court
Suite 400
Englewood, CO 80112
United States
720 437 6500
https://ampiopharma.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 6
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Michael A. Martino | CEO, CFO, General Secretary & Director | 550k | N/D | 1957 |
Dr. David Bar-Or M.D. | Founder & Chairman of Scientific Advisory Board | 145.6k | N/D | 1949 |
April Ramirez | Clinical Trial Manager | N/D | N/D | N/D |
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
La calificación ISS Governance QuickScore de Ampio Pharmaceuticals, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.